Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

American Heart Journal

Volumn 168, Issue 4, 2014, Pages 503-511.e2

  Bagai, Akshay ^a   Schulte, Phillip J ^b   Granger, Christopher B ^b   Mahaffey, Kenneth W ^b   Christenson, Robert H ^c   Bell, Gregory ^d   Lopes, Renato D ^b   Green, Cynthia L ^b   Lincoff, A Michael ^e   Armstrong, Paul W ^f   Roe, Matthew T ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d GENENTECH INC   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVOR; TREATMENT OUTCOME; BLOOD; CANADA; CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRENDS; UNITED STATES;

AGED; BIOLOGICAL MARKERS; CANADA; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; UNITED STATES;

EID: 84922257391     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.06.008     Document Type: Article

References (21)

1. K. Thygesen, J.S. Alpert, and A.S. Jaffe Third universal definition of myocardial infarction Circulation 126 2012 2020 2035
2. R.H. Christenson, R.T. Vollmer, and E.M. Ohman Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group Am J Cardiol 85 2000 543 547
3. R.M. Norris, R.M. Whitlock, and C. Barratt-Boyes Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction Circulation 51 1975 614 620
4. T. Rakowski, A. Dziewierz, and J. Legutko Creatine kinase-MB assessed in patients with acute myocardial infarction correlates with cardiac magnetic resonance infarct size at 6-month follow up Hell J Cardiol 55 2014 4 8
5. P. Grande, C. Christiansen, and A. Pedersen Influence of acute myocardial infarct size on acute and one-year mortality Eur Heart J 4 1983 20 25
6. A.T. Turer, K.W. Mahaffey, and D. Gallup Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction Curr Control Trials Cardiovasc Med 6 2005 12
7. M. Zabel, S.H. Hohnloser, and W. Koster Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis Circulation 87 1993 1542 1550
8. C.B. Granger, K.W. Mahaffey, and W.D. Weaver Pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the Complement Inhibition in Myocardial Infarction Treated With Angioplasty (COMMA) trial Circulation 108 2003 1184 1190
9. E. Bates, C. Bode, and M. Costa Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Circulation 117 2008 886 896
10. A.M. Lincoff, M. Roe, and P. Aylward Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial Eur Heart J 2014 [Epub ahead of print]
11. W.H. Press, S.A. Teukolsky, and W.T. Vetterling Numerical Recipes: The Art of Scientific Computing 3rd ed. 2007 Cambridge University Press Cambridge, England 162
12. R.D. Lopes, Y. Lokhnygina, and V. Hasselblad Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy Trials 14 2013 123
13. A. Halkin, G.W. Stone, and C.L. Grines Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction J Am Coll Cardiol 47 2006 951 961
14. M.B. Nienhuis, J.P. Ottervanger, and M.J. de Boer Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction Am Heart J 155 2008 673 679
15. R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 1989 431 440
16. G.W. Stone, A. Maehara, and B. Witzenbichler Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
17. M.R. Patel, R.W. Smalling, and H. Thiele Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial JAMA 306 2011 1329 1337
18. E. Hedstrom, K. Astrom-Olsson, and H. Ohlin Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion Scand Cardiovasc J 41 2007 44 50
19. D. Tzivoni, D. Koukoui, and V. Guetta Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty Am J Cardiol 101 2008 753 757
20. S. Chia, F. Senatore, and O.C. Raffel Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 415 423
21. R.A. Byrne, G. Ndrepepa, and S. Braun Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 106 2010 1212 1217